跳至主要内容

CDISC’s Requirements About SEND

 

SEND (Standard for Exchange of Nonclinical Data, Non-Clinical Data Interchange Standards Consortium）Clinical Data Interchange Standards Consortium (Clinical Data Interchange Standards Consortium) Numerical formalism.

On September 15th of this year, the FDA CDER issued an enforcement request IND and an NDA/BLA application, supporting the submission of a non-payment test SEND number (Dataset). The Dataset code for the data set is to be confirmed and sent by the FDA SEND formal communication request.

 


Mr. Harahara, Director of FDA standardization research. Origin: FDA

When did it Start to Operate the SEND Dataset?

FDA CDER general request IND on September 15, 2021, support NDA/BLA China-China demand negotiations, non-table trial SEND Dataset, including comprehensive GLP and non-GLP trial. If the SEND Dataset cannot be passed, the FDA approval has been rejected.

 




SENDIG is a reference-specific SDTM model. However, SDTM is a comprehensive model of the original capital. In this case, this small model is compatible with both directions. SENDIG supports multiple-dose general toxicology, multiple-dose general toxicology, carcinogenicity research, and safety science research.

Support for other research categories than SENDIG. For example, SENDIG-DART v1.2 has been established, and DART research collection includes certain specific numerical recommendations, especially embryo-fetal development (EFD) research, and juvenile animal behavioral toxicity research. SENDIG-AR v1.0 Supports the basic infrastructure and ongoing research. In addition to the model implementation guidelines, we will develop the consistency guideline, so you can be sure of the generative number structure combination.



Under what circumstances will FDA refuse to accept a submitted SEND Dataset?

If the submitted SEND Dataset has the following problems, FDA will refuse to accept it:

• Missing corresponding ts.xpt Dataset

• Incorrectly filling in the STF file tag of Dataset

• Missing DM Dataset and define.xml

• Missing STF files

Reference:

[1]. CDISC Website: SEND. https://www.cdisc.org/standards/foundational/send

标签：

评论

发表评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...
发表评论
阅读全文

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...
发表评论
阅读全文

What is Toxicokinetics?

Toxicokinetics  is essentially the study of “how a substance gets into the body and what happens to it in the body”. Four processes are involved in toxicokinetics. The study of the kinetics (movement) of chemicals was originally conducted with pharmaceuticals and thus the term pharmacokinetics became commonly used. In addition, toxicology studies were initially conducted with drugs. However, the science of toxicology has evolved to include environmental and occupational chemicals as well as drugs. Toxicokinetics is thus the appropriate term for the study of the kinetics of all toxic substances. Frequently the terms  toxicokinetics ,  pharmacokinetics , or disposition may be found in the literature to have the same meaning. Disposition is often used in place of toxicokinetics to describe the time-course of movement of chemicals through the body (that is, how does the body dispose of a xenobiotic?). The disposition of a toxicant along with its’ biological reactivi...
发表评论
阅读全文